RE
REGN•United States
Need professional-grade analysis? Visit stockanalysis.com
$741.69
+1.20%
End of day
Market Cap
$83.04B
P/E Ratio
18.94
Employees
N/A
Dividend Yield
0.46%
Price Chart
Risk-Adjusted Performance
Also Listed On
Regeneron Pharmaceuticals Inc (REGN) Price Performance
Regeneron Pharmaceuticals Inc (REGN) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $741.69, up 1.20% from the previous close.
Over the past year, REGN has traded between a low of $481.73 and a high of $812.27. The stock has gained 16.4% over this period. It is currently 8.7% below its 52-week high.
Regeneron Pharmaceuticals Inc has a market capitalization of $83.04B, with a price-to-earnings ratio of 18.94 and a dividend yield of 0.46%.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $13.12B
- EBITDA
- $4.25B
- Profit Margin
- 31.41%
- EPS (TTM)
- 41.47
- Book Value
- 304.65
Technical Indicators
- 52 Week High
- $821.11
- 52 Week Low
- $475.17
- 50 Day MA
- $758.23
- 200 Day MA
- $622.62
- Beta
- 0.41
Valuation
- Trailing P/E
- 18.94
- Forward P/E
- N/A
- Price/Sales
- 5.79
- Price/Book
- 2.59
- Enterprise Value
- $75.15B